本公司合作信息
熱門資訊推薦
- ·千億大健康風口來襲|正康林事業(yè)部 保健品/食品/美妝產品招商,誠邀自主創(chuàng)業(yè)者合作共贏
- ·消毒類產品采購項目,供應商必須提供《消毒產品衛(wèi)生安全評價報告》嗎?
- ·陜西出臺藥品監(jiān)管科學研究項目管理辦法
- ·澤德曼醫(yī)藥與濟川藥業(yè)就澤立美乳膏達成中國獨家商業(yè)化合作
- ·廣西與老撾積極推進傳統(tǒng)醫(yī)藥領域合作
- ·掘金風濕骨痛藍海:古立修三維特色項目,引爆三終端市場的骨病疼痛新紀元!
- ·AI重塑醫(yī)藥創(chuàng)新范式 專家:區(qū)域協(xié)同與國際合作釋放新機遇
- ·修正保健品、食品、美妝事業(yè)部,誠招合作伙伴!
- ·針對腰間椎盤突出、腰肌勞損等腰部問題,錦益堂老膏貼,傳統(tǒng)中草油丹熬制,外敷高端品誠邀合作!
- ·中德跨境醫(yī)藥健康行業(yè)合作交流會舉辦 搭建國際化合作平臺
COOPERATION
發(fā)布時間:2008/7/8 11:06:00 瀏覽次數:485 類別:其它詳情介紹
-
More effective and better foreground-The research and development of a new drug which can replace cardiac pacemaker
Currently, there is not effective drugs which can cure bradycardia, patient with severe symptoms have to use the cardiac pacemaker to sustain life. More than 600 thousand patients will be equipped with cardiac pacemakers each year. Millions of patients are expecting a new drug will can cure this disease and help them get rid of cardiac pacemakers.
To install a cardiac pacemaker not only means a large sum of money , but also the affliction and risks from the clinical operation. What's more, a lot of side effects and restrictions exist and the patient will replace with a new one in a few years. So, it is very urgent to research on some effective new drugs which are effective to patients with bradycardia.
We are physicians chief. Through 27 years in clinical search, we achieved significant therapeutic effects in curing bradycardia (mainly including sick sinus syndrome and third degree Atrio-Ventricular block) with Xindekuai.. Only after oral taking of this medicine for three days, improvement of heart rate, increase in cardiac outputs and improvement of cardiac function can be seen. These make the symptoms decrease or even disappear which enable the patients to survive without cardiac pacemakers. Widely use of the new medicine will alleviate millions of patients who suffer from the disease and also can be taken as a key project in economic exchange with foreign countries.
Xindekuai Prescription has been tested in Pharmacodynamic experiments and toxicological experiments using animal models, which have proven effectiveness.
Xindekuai Prescription has been evaluated by experts appointed by the Chamber of Scinece and Technology of Anhui Province, which has been passed.
Xindekuai Prescription win the 16th Shanghai Execllent-Invention Prize.
Xindekuai Prescription has not acquired the new drug certification up to now, we are eager to cooperate with people with wisdom and ability to develop this promising new drug. There are three advantages in developing this drug:
1. No risk : this new Prescription has been searched clinically for 27 years with excellent therapeutic effects and low adverse effests and low adverse effects. And the tests in animal models also indicate its effectiveness.
2. Low investment, short cycle: because the old drugs have been discovered, which have new use with reasonable and simple prescription.
3. well prospect: millions upon millions of patients are waiting anxi ously for the new drug to come to marker. Welcome to cooperate in developing this promising new drug.
Note: Xindekuai is a kind of compound tablet or capsule,chemical matter has been determined.
Liaison man: Doctor Lin.
聯(lián)系方式
-
聯(lián) 系 人: 林青
聯(lián)系地址: 蚌埠醫(yī)學院二附院
電 話: 0571-85885083



